[1]O’Mahoney L L, Routen A, Gillies C, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis[J]. EClinicalMedicine, 2023, 55: 101762.
[2]Fancello V, Fancello G, Hatzopoulos S, et al. Sensorineural Hearing Loss Post-COVID-19 Infection: An Update[J]. Audiology Research, 2022, 12(3): 307-315.
[3]Owen A J, Tran T, Hammarberg K, et al. Poor appetite and overeating reported by adults in Australia during the coronavirus-19 disease pandemic: A population-based study[J]. Public health nutrition, 2021, 24(2): 275-281.
[4]Czech T, Sugihara S, Nishimura Y. Characteristics of hair loss after COVID‐19: A systematic scoping review[J]. Journal of Cosmetic Dermatology, 2022, 21(9): 3655-3662.
[5]COVID-19: Cutaneous manifestations and issues related to dermatologic care https://www.uptodate.com/contents/covid-19-cutaneous-manifestations-and-issues-related-to-dermatologic-care (2022-01-18)
[6]Blackett J W, Li J, Jodorkovsky D, et al. Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID‐19[J]. Neurogastroenterology & Motility, 2022, 34(3): e14251.
[7]Choudhury A, Tariq R, Jena A, et al. Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis[J]. Therapeutic advances in gastroenterology, 2022, 15: 17562848221118403.
[8]Meyer-Frießem C H, Gierthmühlen J, Baron R, et al. Pain during and after COVID-19 in Germany and worldwide: a narrative review of current knowledge[J]. Pain reports, 2021, 6(1).
[9]Raveendran A V, Jayadevan R, Sashidharan S. Long COVID: an overview[J]. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021, 15(3): 869-875.
[10]Kemp H I, Corner E, Colvin L A. Chronic pain after COVID-19: implications for rehabilitation[J]. British journal of anaesthesia, 2020, 125(4): 436-440.
[11]Rudenstine S, Schulder T, Bhatt K J, et al. Long-COVID and comorbid depression and anxiety two years into the COVID-19 pandemic[J]. Psychiatry Research, 2022, 317: 114924.
[12]Renaud-Charest O, Lui L M W, Eskander S, et al. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review[J]. Journal of psychiatric research, 2021, 144: 129-137.
[13]Mazza M G, Palladini M, Poletti S, et al. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment[J]. CNS drugs, 2022: 1-22.
[14]Lorkiewicz P, Waszkiewicz N. Biomarkers of post-COVID depression[J]. Journal of Clinical medicine, 2021, 10(18): 4142.
[15]Zheng B, Daines L, Han Q, et al. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis[J]. European Respiratory Review, 2022, 31(166).
[16]Robinson P. Long COVID and breathlessness: an overview[J]. British journal of community nursing, 2021, 26(9): 438-443.
[17]Kessler A, Heightman M, Brennan E. Post-COVID-19 respiratory problems: burden and management[J]. Current Opinion in Supportive and Palliative Care, 2022, 16(4): 203-209.
[18]Morrow A K, Malone L A, Kokorelis C, et al. Long-term COVID 19 sequelae in adolescents: the overlap with orthostatic intolerance and ME/CFS[J]. Current pediatrics reports, 2022: 1-14.
[19]van Campen C L M C, Visser F C. Orthostatic intolerance in long-haul COVID after SARS-CoV-2: a case-control comparison with post-EBV and insidious-onset myalgic encephalomyelitis/chronic fatigue syndrome patients[C]//Healthcare. MDPI, 2022, 10(10): 2058.
[20]Davis H E, McCorkell L, Vogel J M, et al. Long COVID: major findings, mechanisms and recommendations[J]. Nature Reviews Microbiology, 2023: 1-14.
[21]Wang S, Quan L, Chavarro J E, et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post–COVID-19 conditions[J]. JAMA psychiatry, 2022, 79(11): 1081-1091.
发表评论
注册或登后即可发表评论
登录注册
全部评论(0)